Abnova Corp. (4133) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Abnova Corp. (4133:TWSE), powered by AI.

Current Price
$20.70
Sector
Healthcare
What is the Abnova Corp. stock price forecast?

Abnova Corp. is currently trading at $20.70. View real-time AI analysis on Alpha Lenz.

What is Abnova Corp. insider trading activity?

View the latest insider trading data for Abnova Corp. on Alpha Lenz.

What is Abnova Corp.'s P/E ratio?

View Abnova Corp.'s valuation metrics on Alpha Lenz.

Abnova Corp.

TWSE · 4133
NT$20.70+0.10(+0.49%)
Ask about Abnova Corp.'s future dividend policy...
Alpha Chat Insight

Abnova Corp.'s ROE is -0.1%. Explore profitability and growth together.

Ask for details

Company Overview

Abnova Corp. is a leading biotechnology company that specializes in the development and production of antibodies and related biological reagents on a commercial scale. Its primary purpose is to supply a diverse range of bio-products for high-throughput research and diagnostic purposes, catering to the needs of scientists and medical researchers globally. With a focus on genomics and proteomics, Abnova leverages cutting-edge technology to produce comprehensive antibody libraries, genetic tools, and diagnostic kits. These products serve critical roles in the pharmaceutical, life sciences, and healthcare sectors by facilitating advanced research and the development of new therapeutic solutions. Headquartered in Taiwan, Abnova Corp. maintains a strong presence in the global biotech market, contributing significantly to advancements in biomarker discovery and personalized medicine. Its extensive pipeline of innovative products underscores its commitment to precision and quality, rendering it a valuable partner for research institutions and biotech companies alike.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$351.30MRevenue
0.00Shares Out
0Employees

Margins

44.35%Gross
7.81%EBITDA
4.97%Operating
-0.58%Pre-Tax
-0.32%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-5.16%Rev 3Yr
-5.10%Rev 5Yr
-35.51%Op Inc 3Yr
-22.26%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-0.08%ROA
-0.09%ROE
-0.12%ROIC

Financial Health

NT$377.83MCash & Cash Equivalents
NT$-307.09MNet Debt
5.63%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Abnova Corp. (ticker: 4133) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 20.7 with a P/E ratio of -x and P/B of -x.

ROE is -0.09% and operating margin is 4.97%. Annual revenue is $351M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Abnova Corp. (4133) Stock Forecast 2026 $20.70 — Price, Financials & Analyst Targets | Alpha Lenz